{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/fr\/","title":"De nouvelles donn\u00e9es t\u00e9moignent de l\u2019int\u00e9r\u00eat th\u00e9rapeutique des agents biologiques dans la ma\u00eetrise de l\u2019asthme \u00e9osinophilique grave - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"UrASZgOTVK\"><a href=\"https:\/\/themedicalxchange.com\/fr\/2016\/10\/19\/congres-international-de-2016-de-leuropean-respi-2\/\">De nouvelles donn\u00e9es t\u00e9moignent de l\u2019int\u00e9r\u00eat th\u00e9rapeutique des agents biologiques dans la ma\u00eetrise de l\u2019asthme \u00e9osinophilique grave<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/fr\/2016\/10\/19\/congres-international-de-2016-de-leuropean-respi-2\/embed\/#?secret=UrASZgOTVK\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0De nouvelles donn\u00e9es t\u00e9moignent de l\u2019int\u00e9r\u00eat th\u00e9rapeutique des agents biologiques dans la ma\u00eetrise de l\u2019asthme \u00e9osinophilique grave\u00a0\u00bb &#8212; The Medical Xchange\" data-secret=\"UrASZgOTVK\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2016\/10\/2360_ERS_2016_fr_Fig_1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"Londres \u2013 Des donn\u00e9es pr\u00e9sent\u00e9es lors du congr\u00e8s de 2016 de l\u2019ERS ont confirm\u00e9 que les agents biologiques ont bel et bien un r\u00f4le d\u00e9terminant \u00e0 jouer dans la ma\u00eetrise de l\u2019asthme \u00e9osinophilique grave. Ces donn\u00e9es sont issues d\u2019essais de phase III ayant port\u00e9 sur un nouvel anticorps monoclonal (AcM) ciblant le r\u00e9cepteur de l\u2019interleukine-5 (IL-5), de nouvelles analyses d\u2019un anti-IL-5 d\u00e9j\u00e0 homologu\u00e9 destin\u00e9 aux populations rebelles aux traitements et d\u2019un essai p\u00e9diatrique sur le premier antiasthmatique biologique homologu\u00e9, qui est dirig\u00e9 contre l\u2019immunoglobuline E (IgE). Tous ces agents ont \u00e9t\u00e9 reli\u00e9s \u00e0 des baisses significatives de l\u2019incidence des exacerbations par rapport au placebo. Des agents biologiques ciblant d\u2019autres m\u00e9diateurs et voies d\u2019activation des \u00e9osinophiles devraient logiquement \u00eatre mis au point, quoiqu\u2019un essai de phase III termin\u00e9 r\u00e9cemment et ayant port\u00e9 sur un AcM oppos\u00e9 \u00e0 l\u2019interleukine 13 (IL-13) ait donn\u00e9 des r\u00e9sultats d\u00e9cevants."}